Search

Advances in the Treatment of CNS Malignancies

Orin Bloch (UCD)

New Therapeutic Options in the Myelodysplastic Syndromes

Brian A. Jonas, MD, PhD, FACP

Immunotherapy in Heme Malignancies

Arta M. Monjazeb, MD, PhD

Updates in Multiple Myelom

Aaron S. Rosenberg, MD, MS

Diffuse Large Cell Lymphoma – The Latest and...

Leslie Popplewell, MD, FACP

Melanoma: Beyond Checkpoint Inhibitors

Sanjiv S. Agarwala, MD

CLL & CML (a lot on the first...

Javier Pinilla-Ibarz, MD, PhD

CLL & CML (a lot on the first...

Javier Pinilla-Ibarz, MD, PhD

Chimeric Antigen Receptor (CAR) T Cell Therapy –...

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

DOACs in Cancer

Craig S. Kitchens,, MD, MACP

Myelodysplasia and Secondary AML

Rami Komrokji, MD

B-Cell NHL and Hodgkin’s Disease

Eduardo M. Sotomayor, MD

How to Decide which Frontline Therapy in MM...

Melissa Alsina, MD

Acute Myeloid and Lymphoid Leukemias

Kevin Kelly, MD, PhD

What New in Hematopoietic Stem Cell Transplantation

Joseph M. Tuscano, MD

Multiple Myeloma Transplant and Non-transplant Modalities

Sikander Ailawadhi, MD

Acute Myeloid and Lymphoid Leukemias

Hugo F. Fernandez, MD

CLL & CML

Mohamed A. Kharfan-Dabaja, MD, MBA

Targeted Therapy for B- and T-cell Non-Hodgkin’s Lymphomas

Eduardo M. Sotomayor, MD

Acute Myeloid and Lymphoid Leukemias

Hugo F. Fernandez, MD